Riskpilot← Back to searchSign inGet full accessHGH EIENDOM AS
ASActiveOrg 994285874Frustuvegen 1, 2408 ElverumRental and operating of own or leased real estate · NACE 6820Est. 20090 employees
Revenue 2024
NOK 637K
-18% vs 2023
EBITDA margin
53.5%
-37% vs 2023
Equity ratio
20.9%
Financial strength
Net profit 2024
NOK -67K
-142% vs 2023
| Revenue | NOK 637K | -18% |
| EBITDA | NOK 341K | -37% |
| Net profit | NOK -67K | -142% |
| Total assets | NOK 4,5M | -29% |
| Equity | NOK 932K | -7% |
| Employees | 0 | — |
Legal name
HGH EIENDOM AS
Org number
994285874
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
20. august 2009
Share capital
NOK 360 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Eiendomsutvikling og det som naturlig hører med til dette.
Address
Frustuvegen 1, 2408 Elverum
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2009 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 226 | 117 | 251 | 274 | 370 | 384 | 454 | 467 | 513 | 578 | 429 | 774 | 637 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −2 | −0 | −0 | −0 | −0 | −0 | −18 | −0 | −0 | −0 |
| EBITDA | −6 | −20 | 208 | −179 | 186 | 201 | 131 | 304 | 321 | 379 | 334 | 257 | 132 | 543 | 341 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | −6 | −20 | 208 | −179 | 186 | 201 | 131 | 304 | 321 | 379 | 334 | 257 | 132 | 543 | 341 |
| Net financials | 0 | 0 | 0 | −73 | −94 | −85 | −110 | −133 | −125 | −141 | −208 | −269 | −329 | −383 | −408 |
| Profit before tax | −6 | −20 | 208 | −252 | 92 | 116 | 22 | 171 | 196 | 237 | 125 | −13 | −198 | 160 | −67 |
| Tax | −0 | −0 | 51 | −70 | 25 | 55 | −21 | 40 | 45 | 52 | 28 | −3 | −4 | −0 | −0 |
| Net profit | −6 | −20 | 157 | −182 | 67 | 61 | 43 | 130 | 151 | 185 | 98 | −10 | −194 | 160 | −67 |
| Item | 2009 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 354 | 333 | 566 | 2 325 | 2 328 | 2 376 | 3 843 | 3 913 | 3 910 | 3 993 | 8 098 | 7 969 | 7 970 | 6 302 | 4 454 |
| Equity | 354 | 333 | 491 | 308 | 375 | 436 | 479 | 609 | 760 | 945 | 1 043 | 1 033 | 839 | 999 | 932 |
| Long-term debt | 0 | 0 | 51 | 1 980 | 1 924 | 0 | 0 | 0 | 0 | 0 | 6 993 | 6 904 | 6 872 | 5 080 | 3 296 |
| Short-term debt | 0 | 0 | 25 | 37 | 29 | 65 | 35 | 96 | 66 | 76 | 62 | 32 | 258 | 223 | 227 |
| Total debt | 0 | 0 | 76 | 2 017 | 1 953 | 1 940 | 3 364 | 3 304 | 3 149 | 3 048 | 7 055 | 6 936 | 7 130 | 5 302 | 3 522 |
EBITDA margin
53.5%
This company
15.8%
Market median
+239% vs market
20092024
Equity ratio
20.9%
This company
38.2%
Market median
-45% vs market
20092024
Return on equity
-7.2%
This company
18.4%
Market median
-139% vs market
20092024
Net profit margin
-10.5%
This company
8.1%
Market median
-230% vs market
20092024
Asset turnover
0.14×
This company
1.12×
Market median
-88% vs market
20092024
Debt / equity
3.78×
This company
0.62×
Market median
-510% vs market
20092024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-05-10 – 2009-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2013 | — | — | |
| Chairman | 2013 | — | — | |
| Board of Directors | 2013 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Regamo As | Company | 33.3% | 33.3% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Regamo As
HGH EIENDOM AS Board members of HGH EIENDOM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kyrre Kjærneth | Board of Directors | 0 companies |
| Helge Hartz | Chairman | 0 companies |
| Jonny Løkken | Board of Directors | 0 companies |